FACTORS ASSOCIATED WITH THE OUTCOME OF PERCUTANEOUS CORONARY INTERVENTION AFTER 6 MONTHS IN PATIENTS ≥75 YEARS OLD WITH ST-ELEVATION MYOCARDIAL INFARCTION
Nội dung chính của bài viết
Tóm tắt
Objective: To evaluate factors associated with the outcomes of percutaneous coronary intervention (PCI) after 6 months in patients aged ≥75 years with ST-elevation myocardial infarction (STEMI).
Subjects and Methods: A prospective, interventional, cross-sectional study was conducted on 104 patients aged ≥75 years, diagnosed with acute STEMI and indicated for PCI at Vietnam National Heart Institute – Bach Mai Hospital, Hanoi Heart Hospital, and Huu Nghi Hospital during the period 2018–2023.
Results: The incidence of major adverse cardiovascular events (MACE) at 6 months post-PCI was 18.3%. The risk factors significantly associated with MACE were: age ≥85 years (OR = 5.39; p = 0.020), diabetes mellitus (OR = 2.95; p = 0.037), Killip class III+IV (OR = 4.44; p = 0.011), TIMI risk score >6 (OR = 3.84; p = 0.019), CK-MB >39 (OR=3.35, p = 0.019), TroponinT T>4084.2 ng/L (OR = 8.02, p<0.001), ST-segment elevation ≥4.0 mm (OR = 4.03; p = 0.009), triple-vessel disease (OR = 3.39; p = 0.016), and left main coronary artery (LMCA) lesion (OR = 4.27; p = 0.046).
Conclusion: The factors associated with adverse outcomes following PCI in patients aged ≥75 years with STEMI within 6 months were advanced age, diabetes, high Killip class, elevated TIMI score (>6), lower CK-MB concentration, Troponin T concentration, ST elevation ≥4.0 mm, triple-vessel coronary artery disease, and LMCA involvement.
Chi tiết bài viết
Từ khóa
Primary coronary intervention, myocardial infarction, ST elevation, ≥75 years old.
Tài liệu tham khảo
[2] Perl Leor, Franzé Alfonso, D’Ascenzo Fabrizio, et al. (2021). Elderly Suffering from ST-Segment Elevation Myocardial Infarction—Results from a Database Analysis from Two Mediterranean Medical Centers10(11): 2435.
[3] Soleimani HR, Masoudkabir F, Mehrani M, et al. (2024). Nomogram-based prediction of MACE in older adults with STEMI. European Heart Journal, 45(Supplement_1): ehae666.1490.
[4] Zhang Chengzhi, Yang Jiajuan, Zeng Ping, et al. Association between Admission Blood Glucose and In-Hospital MACE in Non-Diabetic STEMI (Killip I) Patients Undergoing Primary PCI. in The Heart Surgery Forum. 2025.
[5] Van Diepen Sean, Katz Jason N, Albert Nancy M, et al. (2017). Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation, 136(16): e232-e268.
[6] Nakamura Takuya, Watanabe Makoto, Sugiura Junichi, et al. (2024). Prognostic impact and predictors of persistent renal dysfunction in acute kidney injury after percutaneous coronary intervention for acute myocardial infarction. Scientific Reports, 14(1): 6299.
[7] Christensen Martin Kirk, Huang Hui, Torp-Pedersen Christian, et al. (2016). Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study. BMC Cardiovascular Disorders, 16(1): 140.
[8] Biener Moritz, Giannitsis Evangelos, Hogrefe Katharina, et al. (2022). Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: A validation study. Clinical Research in Cardiology, 111(3): 333-342.
[9] López-Pérez Manuel, Estévez-Loureiro Rodrigo, López-Sainz Ángela, et al. (2014). Long-term prognostic value of mitral regurgitation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. The American journal of cardiology, 113(6): 907-912.
[10] Mohr Friedrich W, Morice Marie-Claude, Kappetein A Pieter, et al. (2013). Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. The lancet, 381(9867): 629-638.